Compound A Select compound… 5-Amino-1MQ Amlexanox AOD-9604 Argireline BPC-157 Buserelin Cagrilintide Carnosine CJC-1295 Cortexin Crystagen Dihexa DSIP Epithalon Follistatin 344 FOXO4-DRI GHK GHK-Cu GHRP-2 GHRP-6 Glandokort Gonadorelin hCG HGH Fragment 176-191 Humanin IGF-1 DES IGF-1 LR3 Ipamorelin Kisspeptin KPV Liraglutide Livagen LL-37 Melanotan I Melanotan II MK-677 MOTS-c NAD+ Noopept NSI-189 Oxytocin P21 PEG-MGF Pinealon Pramlintide PT-141 Retatrutide Retinalamin Selank Semaglutide Semax Sermorelin SS-31 Svetinorm TB-500 Tesamorelin Tesofensine Thymalin Thymosin Alpha-1 Tirzepatide Triptorelin Ventfort Vesugen Vilon VIP
vs
Compound B Select compound… 5-Amino-1MQ Amlexanox AOD-9604 Argireline Buserelin Cagrilintide Carnosine Cerebrolysin CJC-1295 Cortexin Crystagen Dihexa DSIP Epithalon Follistatin 344 FOXO4-DRI GHK GHK-Cu GHRP-2 GHRP-6 Glandokort Gonadorelin hCG HGH Fragment 176-191 Humanin IGF-1 DES IGF-1 LR3 Ipamorelin Kisspeptin KPV Liraglutide Livagen LL-37 Melanotan I Melanotan II MK-677 MOTS-c NAD+ Noopept NSI-189 Oxytocin P21 PEG-MGF Pinealon Pramlintide PT-141 Retatrutide Retinalamin Selank Semaglutide Semax Sermorelin SS-31 Svetinorm TB-500 Tesamorelin Tesofensine Thymalin Thymosin Alpha-1 Tirzepatide Triptorelin Ventfort Vesugen Vilon VIP
Molecular weight
1419.53 g/mol
—
Half-life
~4 hours (stable in gastric juice — unique among peptides)
—
Admin routes
subcutaneous intramuscular oral topical
—
Research areas
Tendon/ligament repair Gut healing (IBD, ulcers, leaky gut) Muscle injury recovery Neuroprotection Bone fracture healing Wound healing Organ protection (liver, pancreas, heart)
—
Typical dosing
250–500 mcg · 1-2x daily · 4-12 weeks
—
FDA status
Not FDA-approved and NOT compoundable as of June 2026 (per regulatory-status-refresh-2026-06): removed from the Category 2 do-not-compound list in April 2026 (nomination withdrawn, effective 2026-04-23) — this is a procedural step, not approval, and BPC-157 is NOT Category 1. PCAC review scheduled Jul 23, 2026. Also WADA-prohibited (S0).
not-FDA-approved
WADA status
Prohibited (S0 category — non-approved substances, effective January 2022)
—
